|
|
|
|
 |
|
|
|
|
Print
|
|
|
|
|
Last modified on 8/4/2008 3:28:53 PM
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| What's New! | |
|
| Association Bulletin #08-04 - Strategies to Reduce Adverse Reactions and Injuries in Younger Donors |
|
| Details |
| |
|
| AABB Weekly Report - August 22, 2008 |
|
| Details |
| |
|
| Summary of Draft Comments to be Submitted to TJC on Blood Management Performance Measures |
|
| Details |
| |
|
| Significant Changes to the Standards for Cellular Therapy Product Services, 3rd edition |
|
| Details |
| |
|
| Proposed 6th edition of Standards for Immunohematology Reference Laboratories |
|
| Details |
| |
|
| First Ever National Biovigilance Network in the U.S. Reaches $1 Million in Funding, Prepares for Fall Pilot Launch |
|
| Details |
| |
|
| Billing and Reimbursement for Stem Cell Processing - Frequently Asked Questions and Answers |
|
| Details |
| |
|
| 2008 West Nile Virus Biovigilance Network |
|
| Details |
| |
|
| List of AABB-Accredited Facilities with Approved Variances for ISBT 128 |
|
| Details |
| |
|
| Instructions on Applying for an AABB Variance |
|
| Details |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|